Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout
Stitch-seq 通过 RNA-seq 读数进行全基因组汇集基因组筛选
基本信息
- 批准号:10413630
- 负责人:
- 金额:$ 20.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-10 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAffectBar CodesBehaviorBiological AssayBiologyCRISPR interferenceCRISPR screenCRISPR-mediated transcriptional activationCell LineCell modelCellsClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesComplementary DNACustomDataDiseaseDrug resistance pathwayEmulsionsEngineeringEnsureEpithelialEquilibriumExpression ProfilingGene ExpressionGene Expression ProfilingGene PoolGenerationsGenesGenetic ScreeningGenomic approachGenomicsGoalsGuide RNAHealthKnock-outLibrariesLinkLiquid substanceMCF10A cellsMalignant NeoplasmsMammary Gland ParenchymaMesenchymalMessenger RNAMethodsModalityMonitorNaturePathway interactionsPerformancePharmacotherapyProblem SolvingPublishingRNA SequencesReactionReagentRegulator GenesReproducibilityResourcesReverse Transcriptase Polymerase Chain ReactionRunningScreening ResultSignal TransductionTechnologyTestingTimeTranscriptWorkanticancer researchbasebase editingcostexperimental studyfitnessfunctional genomicsgene panelgenetic associationgenetic elementgenome wide screengenome-wideindexinginterestnovelprime editingscreeningsolution hybridizationtranscriptome sequencingwasting
项目摘要
PROJECT SUMMARY
Large-scale pooled CRISPR screens have proven to be a powerful approach to identify genes that affect cell
state and behavior. Notwithstanding the countless genetic associations discovered with proliferation and drug
resistance pathways using viability or marker-based enrichment screens, there is tremendous potential for
pooled screens to go further by incorporating high complexity readouts like gene expression profiles. The cancer
community is already acting on this opportunity to access new pathways and immediately gain mechanistic
information about the nature of screening hits by interpreting the impact of perturbations on expression profiles.
However, pooled gene expression screens are underutilized and not routinely applied for large (eg. genome-
wide) screens for a simple reason - the cost of processing so many cells for single-cell gene expression readout
and carrying out the massive amount of sequence data generation required is too high.
Here, we propose to solve this problem with a method we call Stitch-seq, an ultra-high-throughput droplet-based
overlap PCR method that enables readout of the expression levels of a target gene panel in the pooled screening
context. Stitch-seq is low-cost because it does not require specialized barcoded reagents like beads and
operates as a massively parallel single-cell emulsion Rt-PCR that physically links CRISPR guide RNA
sequences to the targeted mRNA sequences by overlap extension. In the proposed work, we will characterize
the quantitative performance of the Stitch-seq reaction in detail, and demonstrate the technical and cost
performance of Stitch-seq in targeted and genome-wide screens. Stitch-seq will address the significant
throughput limitations associated with existing pooled CRISPR expression screening modalities by providing a
facile, low-cost, and ultra-high-throughput method to physically link perturbations to gene sets of interest across
a range of perturbation modalities including all manner of CRISPR perturbations (knock-out, CRISPRi,
CRISPRoff, CRISPRa, base editing, prime editing, etc.) and beyond.
项目摘要
事实证明,大型合并CRISPR屏幕是识别影响细胞的基因的强大方法
状态和行为。尽管有无数的遗传关联是通过增殖和药物发现的
使用生存能力或基于标记的富集屏幕的电阻途径,具有巨大的潜力
汇总屏幕可以通过结合诸如基因表达曲线之类的高复杂性读数来进一步发展。癌症
社区已经在这一机会访问新途径并立即获得机理
通过解释扰动对表达曲线的影响,有关筛选命中的性质的信息。
然而,汇集基因表达筛选未被充分利用,并且不常规应用于大(例如,基因组 -
宽)屏幕是出于简单的原因 - 处理如此多单元的单细胞基因表达读数的成本
而且,进行大量序列数据生成的数量太高。
在这里,我们建议通过一种我们称为“超高通知液滴” stitch-seq的方法来解决此问题
重叠PCR方法,可以读取合并筛选中目标基因面板的表达水平
语境。针迹seq是低成本的,因为它不需要专门的条形码试剂,例如珠子和
作为一个大规模平行的单细胞乳液RT-PCR,可将CRISPR指南RNA链接起来
通过重叠延伸到靶向mRNA序列的序列。在拟议的工作中,我们将表征
详细详细的针迹反应的定量性能,并证明了技术和成本
针迹在靶标和全基因组筛选中的性能。针迹塞克将解决重要的问题
与现有的合并CRISPR表达筛选方式相关的吞吐量限制通过提供
轻松,低成本和超高通量方法将扰动物理上的扰动与各个兴趣的基因集联系起来
各种扰动方式包括各种CRISPR扰动(淘汰赛,Crispri,
CRISPROFF,CRISPRA,基础编辑,主要编辑等)及以后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Clark Blainey其他文献
Paul Clark Blainey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Clark Blainey', 18)}}的其他基金
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
- 批准号:
10729566 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout
Stitch-seq 通过 RNA-seq 读数进行全基因组汇集基因组筛选
- 批准号:
10620301 - 财政年份:2022
- 资助金额:
$ 20.78万 - 项目类别:
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
改变抗生素发现的创新技术。
- 批准号:
10463689 - 财政年份:2019
- 资助金额:
$ 20.78万 - 项目类别:
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
改变抗生素发现的创新技术。
- 批准号:
10242004 - 财政年份:2019
- 资助金额:
$ 20.78万 - 项目类别:
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
改变抗生素发现的创新技术。
- 批准号:
10670189 - 财政年份:2019
- 资助金额:
$ 20.78万 - 项目类别:
High-content optical pooled genome-wide screens of SARS-CoV-2 infection
SARS-CoV-2 感染的高内涵光学汇集全基因组筛查
- 批准号:
10166221 - 财政年份:2017
- 资助金额:
$ 20.78万 - 项目类别:
Automated and sensitive genomic co-profiling for precision pharmacogenomics
用于精准药物基因组学的自动化、灵敏的基因组共同分析
- 批准号:
9303306 - 财政年份:2016
- 资助金额:
$ 20.78万 - 项目类别:
Microfluidic sample preparation for genomic sequencing of clinical pathogen isolates
用于临床病原体分离株基因组测序的微流控样品制备
- 批准号:
9018768 - 财政年份:2016
- 资助金额:
$ 20.78万 - 项目类别:
相似国自然基金
采用积分投影模型解析克隆生长对加拿大一枝黄花种群动态的影响
- 批准号:32301322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
山丘区农户生计分化对水保措施采用的影响及其调控对策
- 批准号:42377321
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
跨期决策中偏好反转的影响因素及作用机制:采用体验式实验范式的综合研究
- 批准号:72271190
- 批准年份:2022
- 资助金额:43 万元
- 项目类别:面上项目
农民合作社视角下组织支持、个人规范对农户化肥农药减量增效技术采用行为的影响机制研究
- 批准号:72103054
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
采用磁共振技术研究帕金森病蓝斑和黑质神经退变及其对大脑结构功能的影响
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
- 批准号:
10826673 - 财政年份:2024
- 资助金额:
$ 20.78万 - 项目类别:
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 20.78万 - 项目类别:
Impact of Medicaid Prescription Cap Policies on Treatment Outcomes for Opioid Use Disorder: A National Mixed Methods Study
医疗补助处方上限政策对阿片类药物使用障碍治疗结果的影响:一项国家混合方法研究
- 批准号:
10637024 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
- 批准号:
10677075 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别: